Table of Contents
| << Previous Issue | Apr 2016 (Vol: 2016, Issue: 4) | Next Issue >> |
- Section: Licensing
-
Allergan Bolsters its CNS Pipeline with Heptares’ GPCR Targeted Therapies
- Section: Mergers & Acquisitions
-
BMS seeks to invigorate its autoimmune pipeline with acquisition of Padlock
-
Vectura Acquires SkyePharma for US$628 M to Lead in Inhalation Devices
-
Gilead Acquires NASH Candidate from Nimbus to Strengthen its Liver Disease Portfolio
- Section: Research & Development
-
Sanofi Signs US$2.26 B Deal with Start-Up DiCE Molecules to Develop Next-Generation Oral Therapeutics
PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.



RSS